Trinity Biotech (TRIB) Profit After Tax Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) Profit After Tax Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.50 Mn | 1.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,612.32% |
| Sep 30, 2024 | -8,519.92% |
| Jun 30, 2024 | -4.57% |
| Mar 31, 2024 | -73.50% |
| Dec 31, 2023 | 26.05% |
| Sep 30, 2023 | -77.81% |
| Jun 30, 2023 | -5,697.98% |
| Mar 31, 2023 | -5,015.43% |
| Dec 31, 2022 | 24.57% |
| Sep 30, 2022 | -78.07% |
| Jun 30, 2022 | -67.58% |
| Mar 31, 2022 | -4,616.47% |
| Dec 31, 2021 | -1,128.33% |
| Sep 30, 2021 | 35.76% |
| Jun 30, 2021 | -20.24% |
| Mar 31, 2021 | 27.18% |
| Dec 31, 2020 | -42.94% |
| Sep 30, 2020 | -9.79% |
| Jun 30, 2020 | -14.87% |
| Mar 31, 2020 | -14.87% |